[go: up one dir, main page]

GR3033678T3 - Imidazolylphenol derivatives, medicaments containing them and a process for the preparation of these compounds and medicaments. - Google Patents

Imidazolylphenol derivatives, medicaments containing them and a process for the preparation of these compounds and medicaments.

Info

Publication number
GR3033678T3
GR3033678T3 GR20000401365T GR20000401365T GR3033678T3 GR 3033678 T3 GR3033678 T3 GR 3033678T3 GR 20000401365 T GR20000401365 T GR 20000401365T GR 20000401365 T GR20000401365 T GR 20000401365T GR 3033678 T3 GR3033678 T3 GR 3033678T3
Authority
GR
Greece
Prior art keywords
medicaments
compounds
preparation
denotes
derivatives
Prior art date
Application number
GR20000401365T
Other languages
English (en)
Inventor
Joachim Dr Ammann
Michael Dr Haurand
Cornelia Dr Geist
Werner Dr Englberger
Oswald Dr Zimmer
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of GR3033678T3 publication Critical patent/GR3033678T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GR20000401365T 1992-02-17 2000-06-14 Imidazolylphenol derivatives, medicaments containing them and a process for the preparation of these compounds and medicaments. GR3033678T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4204686A DE4204686A1 (de) 1992-02-17 1992-02-17 Imidazolylphenolderivate, diese enthaltende arzneimittel sowie ein verfahren zur herstellung dieser verbindungen und arzneimitteln

Publications (1)

Publication Number Publication Date
GR3033678T3 true GR3033678T3 (en) 2000-10-31

Family

ID=6451889

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000401365T GR3033678T3 (en) 1992-02-17 2000-06-14 Imidazolylphenol derivatives, medicaments containing them and a process for the preparation of these compounds and medicaments.

Country Status (9)

Country Link
US (1) US5356921A (el)
EP (1) EP0557787B1 (el)
JP (1) JPH069571A (el)
AT (1) ATE193283T1 (el)
DE (2) DE4204686A1 (el)
DK (1) DK0557787T3 (el)
ES (1) ES2149783T3 (el)
GR (1) GR3033678T3 (el)
PT (1) PT557787E (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2210905A1 (en) * 1995-02-02 1996-08-08 Nikken Chemicals Co., Ltd. N-hydroxyurea derivatives
DE69830929T2 (de) 1997-11-11 2006-04-20 Nikken Chemicals Co., Ltd. N-hydroxyurea-derivat und dieses enthaltende pharmazeutische zusammensetzung
WO2002088071A1 (fr) 2001-04-26 2002-11-07 Taisho Pharmaceutical Co., Ltd. Inhibiteurs de la production d'acide 20-hydroxyeicosatetraenoique
EP3563842A1 (en) 2009-04-29 2019-11-06 Amarin Pharmaceuticals Ireland Limited Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
EP3268085A4 (en) 2015-03-13 2018-10-31 The Board of Trustees of The Leland Stanford Junior University Ltb4 inhibition to prevent and treat human lymphedema
WO2020039088A2 (en) * 2018-08-24 2020-02-27 Xeniopro GmbH Novel compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
DK471479A (da) * 1978-12-13 1980-06-14 Pfizer Fremgangsmaade til fremstilling af imidazolderivater og salte deraf
JPS58150566A (ja) * 1982-03-03 1983-09-07 Yoshitomi Pharmaceut Ind Ltd 新規イミダゾ−ル誘導体
DE3424944A1 (de) * 1984-07-06 1986-02-06 Hoechst Ag, 6230 Frankfurt Neue imidazolyverbindungen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE80611T1 (de) * 1985-03-16 1992-10-15 Wellcome Found Aryl-derivate.
GB2185741B (en) * 1986-01-27 1989-10-25 American Home Prod Heterocyclic sulphonamides
US5026729A (en) * 1987-02-10 1991-06-25 Abbott Laboratories Lipoxygenase inhibiting compounds
ES2053609T3 (es) * 1987-04-24 1994-08-01 Abbott Lab Derivados de urea inhibidores de lipoxigenasa.
GB8820185D0 (en) * 1988-08-25 1988-09-28 Wellcome Found New medical use
PT93049A (pt) * 1989-02-03 1990-08-31 Wellcome Found Processo para a preparacao de compostos de aril-hidroxi-ureia possuindo actividade anti-inflamatoria e de composicoes farmaceuticas que os contem
WO1990012008A1 (en) * 1989-03-30 1990-10-18 Abbott Laboratories Urea based lipoxygenase inhibiting compounds
US5220059A (en) * 1990-04-19 1993-06-15 Abbott Laboratories Lipoxygenase-inhibiting compounds derived from non-steroidal antiinflammatory carboxylic acids

Also Published As

Publication number Publication date
JPH069571A (ja) 1994-01-18
EP0557787B1 (de) 2000-05-24
PT557787E (pt) 2000-10-31
HK1010106A1 (en) 1999-06-11
ATE193283T1 (de) 2000-06-15
DE59310044D1 (de) 2000-06-29
DK0557787T3 (da) 2000-10-30
US5356921A (en) 1994-10-18
DE4204686A1 (de) 1993-08-19
EP0557787A1 (de) 1993-09-01
ES2149783T3 (es) 2000-11-16

Similar Documents

Publication Publication Date Title
IL101819A0 (en) Amidinophenylalanine derivatives,a process for the preparation thereof,use thereof and agents containing these as anticoagulants
ZA925128B (en) Pyrrolidine derivatives,their preparation and medicaments containing them
ZA926328B (en) Naphthylethylureas and naphthylethylthioureas process for the preparation thereof and pharmaceutical compositions containing them.
EP0582198A3 (de) Substituierte (Hetero-)Arylverbindungen, Verfahren zu deren Herstellung, diese enthaltende Mittel und deren Verwendung als Safener.
HUT67924A (en) Fungicidal compositions containing 2-(substituted phenyl)-3-methoxy-propenecarboxylates as active ingredients, process for producing the active ingredients, and method for combatting fungi
ZA932168B (en) Naphthylalkylamines, process for preparing them and pharmaceutical compositions containing them
AU2067692A (en) New 5-isoquinolinesulfonamides process for preparing them and pharmaceutical compositions containing them
CA2119853A1 (fr) Nouvelles pyridothiadiazines, leurs procedes de preparation, et les compositions pharmaceutiques qui les contiennent
HUT59139A (en) Process for producing tricyclic compounds and antimicrobial pharmaceutical compositions comprising same
AU3860893A (en) New benzimidazole compounds, a process for their preparation and pharmaceutical compositions containing them
GR3033678T3 (en) Imidazolylphenol derivatives, medicaments containing them and a process for the preparation of these compounds and medicaments.
ZA944728B (en) alph -amino acid compounds a process for the preparation thereof and pharmaceutical compositions containing them
GR3022889T3 (en) 4-amino-2-ureido-5-pyrimidincarboxamide, process for their preparation, medicines containing those compounds and their use
GR3020190T3 (en) Diclofenac choline salt, a method for the preparation thereof and pharmaceutical compositions containing it
ZA932359B (en) 3-Aminochroman spiro compounds processes for preparing them and pharmaceutical compositions containing them
AU679132B2 (en) New eburnane analogues, a process for the preparation thereof and pharmaceutical compositions containing them
MY109729A (en) Benzofuranylimidazole derivatives, a process for the preparation and therapeutical compositions containing the same
GB9318790D0 (en) Heterocyclic derivatives
ZA934110B (en) Diacylglycerol nicotinates, process fot their preparation and the pharmaceutical compositions which contain them
GR3021765T3 (en) Aminoalkylchomones, process for their preparation and pharmaceutical compositions containing them.
TW232011B (el)
IL101286A0 (en) Phenol ethers,processes for the preparation thereof and pharmaceutical compositions containing them
EP0062236A3 (en) Fungicidal agent containing triazole derivatives, and process for combating fungi therewith
ZA945331B (en) Benzospiroalkene compounds process for preparing them and pharmaceutical compositions containing them
IL71430A (en) 2-imino-n-phenylsulfonyl-imidazolidine derivatives,process for the manufacture thereof and pharmaceutical preparations containing such compounds

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees